Adlai Nortye (ANL) Retained Earnings (2022 - 2025)
Adlai Nortye's (ANL) quarterly Retained Earnings came in at -$464.8 million in Q4 2025, down 8.28% year-on-year from -$506.8 million in Q4 2024, and down 3.84% on a QoQ basis from -$447.7 million in Q2 2025.
Adlai Nortye (ANL) Retained Earnings (2022 - 2025) Analysis & Trends
Adlai Nortye (ANL) has 4 years of Retained Earnings data on file, last reported at -$464.8 million in Q4 2025.
- On a quarterly basis, Retained Earnings fell 8.28% year-over-year to -$464.8 million in Q4 2025; TTM through Dec 2025 was -$464.8 million, a 8.28% decrease from a year earlier, with the FY2025 full-year figure at -$464.8 million, down 8.28% from the prior year.
- Retained Earnings for Q4 2025 stood at -$464.8 million, down from -$447.7 million in the prior quarter.
- Over the last five years, Retained Earnings for ANL reached as high as $6.4 million in Q4 2022 and fell as low as -$464.8 million in Q4 2025.
- Historically, Retained Earnings has averaged -$288.6 million across 4 years, with a median of -$415.0 million in 2024.
- Across the five-year window, Retained Earnings sank 9857.23% in 2024 and dropped 8.28% in 2025, its largest moves.
- Year by year, Retained Earnings stood at $6.4 million in 2022, then tumbled by 31.41% to $4.4 million in 2023, then sank by 9857.23% to -$429.3 million in 2024, then fell by 8.28% to -$464.8 million in 2025.
- Per Business Quant data, the three most recent Retained Earnings figures were -$464.8 million in Q4 2025, -$447.7 million in Q2 2025, and -$429.3 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -27.89 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -279.01 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 12.91 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -622,000.00 |
| 10 | Adlai Nortye | 1.16 Bn | 1.15 Bn | - | -464.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -464.85 Mn |
| Jun 30, 2025 | -447.65 Mn |
| Dec 31, 2024 | -429.32 Mn |
| Jun 30, 2024 | -400.70 Mn |
| Dec 31, 2023 | 4.40 Mn |
| Dec 31, 2022 | 6.42 Mn |